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Viral protein-induced apoptosisNon-structural poliovirus 2B protein induces plasma membrane permeabilization and has been recently
implicated in triggering apoptosis via the mitochondrial pathway. Here we describe that the pore-forming P3
peptide, based on the 2B amphipathic domain, translocates through the plasma membrane of culture cells
and targets mitochondria. Cell permeabilization by P3 versions of different lengths, together with peptide
uptake analyses supported an internalization mechanism dependent on P3 capacity to interact physically
with lipid bilayers and establish permeating pores therein. Internalized P3 was found associated with
mitochondria, but contrary to the parental 2B protein, the short peptide did not affect the morphology or cell
distribution of these organelles, nor induced apoptosis. We conclude that P3 constitutes a mitochondrio-
tropic sequence, which is however devoid of 2B pro-apoptotic activity.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
The viroporin family includes viral proteins with potential mem-
brane permeabilizing activity [1–4]. The poliovirus (PV) 2B product has
been described as a prototypical member of this family [3,5]. PV 2B
shares several structural characteristics with other viroporin members
including its small size (less than 100 aa), the absence of glycosilation
and a high degree of hydrophobicity [3]. This latter property enables 2B
insertion intomembranes as an integral product [5,6]. Uponmembrane
insertion, PV 2B tends to oligomerize assembling hydrophilic pores [7].
Recent functional analyses have revealed that viroporins could be
further involved in the induction of an apoptotic response in
mammalian cells during virus infection [8]. PV 2B expression from a
Sindbis virus (SV) replicon induces degradation of internucleosomal
DNA and generation of apoptotic bodies [8]. The expressed 2B product
was partially associated with mitochondria and found to alter the
normal morphology of these organelles. In addition, cytochrome c
release and caspase-3 activationwere evidenced upon 2B expression. It
was therefore concluded that 2B triggers programmed cell death
through the mitochondrial pathway.
In a more general sense, these observations imply that viroporins
may represent a subset of the viral proapoptotic proteins thatV/EHU) and Departamento de
asco, Aptdo. 644, 48080 Bilbao,
nal Cancer Institute, Frederick,
ll rights reserved.translocate into mitochondrial membranes and induce their permea-
bilization [9,10]. It has been pointed out that these proteins invariably
contain amphipathic α-helices required for their activity and seem to
have pore-forming properties [10]. According with this idea, the 2B
sequence bears a Lys-based amphipathic domain (Fig. 1A), which is
conserved among the members of the Picornaviridae family [5,6,11]
and required for its interaction with cell and model membranes
[2,5–7,11–13]. A peptide representing this sequence, designated as P3,
was shown to effectively permeabilize the plasmamembrane to small
solutes when externally added to cultured cells, an activity that
correlated with its capacity for establishing permeating pores in lipid
vesicles [14]. Furthermore, conductance measurements of cells
recorded in whole-cell conﬁguration conﬁrmed the assembly of ion-
conducting P3 channels [14]. In view of the experimental evidence, it
was concluded that this short peptide could mimic the pore-forming
activity of 2B viroporin.
Currently proposed molecular mechanisms establish a link be-
tween pore-formation and peptide translocation across membranes,
at least in some instances (see for reviews [15–19] and for extensive
discussions [20,21]). In linewith this postulate, we report here that the
pore-forming P3 peptide efﬁciently translocates through the plasma
membrane of culture cells. However, in contrast to the general trend
followed by non-permeabilizing cell-penetrating peptides [18,22], or
pore-formingmammalian antimicrobial peptides that translocate into
cultured cells [23–26], the 2B-derived peptide displayed strong
mitochondrial localization. This observation prompted us to assess
further its capacity to mimic pro-apoptotic 2B activity. The confocal
microscopy data indicated that P3 did not affect the mitochondrial
morphology or cell distribution. Furthermore, this sequence was
Fig. 1. Implication of the amphipathic sequence on membrane interactions and cell-permeabilizing capacities of P3. (A) PV 2B sequence hydrophobic moment in the α-helical
conformation, calculated with a sliding window of 11 amino acids and Kyte–Doolitle hydrophobicity scale. The amphipathic domain (sequence above) spans the peak region colored
in black. The sequences and designations of derived peptides used to assess membrane interactions and cell-permeabilizing activity are shown below. (B) Left: CD spectra of P3–23,
P3–18 and P3–15 peptides in buffer containing 50 mM SDS. Center: increase of lateral surface pressure induced by peptide insertion into a phosphatidylcholine (PC) monolayer
initially compressed at 20 mN/m. Peptides (0.5 μM) were injected into the subphase at the time indicated by the arrow. Right: kinetics of aqueous contents release from large
unilamellar vesicles. Peptides (4 μM)were injected into a stirring solution of PC vesicles (100 μM) at time=50 s. (C)Membrane permeabilization to translation inhibitor hygromycin
B (HB) estimated from the reduction in protein synthesis. Left panel: cells were incubated with P3-23, P3-18 or P3–15 for 1 h before HB addition and then with [35S]Met/Cys for
40 min in the presence of the antibiotic. Right panel: control disclosing membrane permeabilization induced by the 2B protein expressed from “repC+2B” Sindbis virus (SV)
replicon as previously described [34]. Most cells were efﬁciently transfected and so only the expression of the SV capsid protein (C) and 2B is detected. C expression does not affect
membrane permeability as described previously. (D) Levels of cell permeabilization to HB induced by the different peptides for 1 h at a concentration of 5 μM, presented as protein
synthesis reduction in HB-treated cells compared with that of untreated cells. The percentages of protein synthesis represent the mean of two experiments.
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activation exhibited by the parental protein. Thus, this short peptide
was not sufﬁcient to recapitulate the pro-apoptotic effects of the full-
length 2B protein. We conclude that P3 mimics only partially the 2B
viroporin activity measured in cells.
2. Materials and methods
The poliovirus 2B-derived P3-15, P3-18, P3-23 (Fig. 1A) and P3-25
(Fig. 2A) peptides were produced by solid-phase synthesis using Fmoc
chemistry as C-terminal carboxamides and puriﬁed by HPLC at the
Proteomics Section of the University Pompeu-Fabra (Barcelona, Spain).
1-palmitoyl-2-oleoylphosphatidylcholine (PC) was purchased from
Avanti Polar Lipids (Birmingham, AL, USA). The 8-aminonaphtalene-
1,3,6-trisulfonic acid sodium salt (ANTS), p-xylenebis(pyridinium)
bromide (DPX), Mitotracker Red CMH2Ros, Alexa 488-conjugatedgoat anti-mouse IgG and Alexa 594-conjugated goat anti-rabbit IgG
were obtained from Molecular Probes (Junction City, OR, USA).
Fluorescein-conjugated streptavidin (Strep-FITC) was supplied by
Sigma (St. Louis, MO, USA). All other reagents were of analytical grade.
Circular dichroism and lipid monolayer measurements have been
described in detail elsewhere [14]. Vesicle permeabilization was
assayed following the ANTS/DPXmethod [27] as previously described
[7,14]. For the cell permeabilization assays baby hamster kidney
(BHK-21) cells were grown at 37 °C in Dulbecco's modiﬁed Eagle
medium (DMEM) supplemented with 5% fetal calf serum (FCS) and
non-essential amino acids. Peptide-induced membrane permeabiliza-
tion was achieved by incubating BHK-21 cells with the peptides in
FCS-free DMEM. Cells were subsequently treated with 1 mM hygro-
mycin B (HB) for 20 min at 37 °C. Proteins were then radiolabeled for
40 min with 10 μCi of [35S]Met-Cys (Promix; Amersham Pharmacia)
as previously described [28]. Protein synthesis was analyzed by SDS-
Fig. 2. Kinetics of P3-induced permeabilization and its internalization into BHK-21 cells. (A) Sequence of P3–25. (B) Binding to BHK-21 cell surface and internalization. Cells were
treated with 1 μM P3–25 (+P3) for 1 h, or left untreated (BHK). After ﬁxation, cells were labeled with Strep-FITC and analyzed in a confocal microscope (NP). Alternatively, the cells
were permeabilized before Strep-FITC labeling (TX-100). (C) P3–25 internalization as a function of time. Histograms obtained by ﬂow cytometry after incubating cells with 1 μM
peptide are shown together with micrographs that illustrate the level of internal labeling at the different incubation times (insets). Black and gray controls correspond to untreated
BHK cells and cells incubated with Strep-FITC alone, respectively. (D) Kinetics of cell membrane permeabilization to HB induced by 2.5 μM P3-25. (E) Levels of cell permeabilization
(circles and solid line) and peptide internalization (squares and dotted line) as a function of time. The values represent, respectively, the percentage of HB-induced protein synthesis
inhibition (panel D), and the percentage of cells emitting ﬂuorescence above the background level (gray histogram in panel C). (F) P3-25 internalization at low temperature
conditions. BHK cells were incubated in the presence of 1 μM P3–25 at 37 °C (left graph) or at 4 °C (middle graph) for the indicated periods of time. Transferrin-FITC (20 μg/ml)
internalization by means of receptor-mediated endocytosis at 37 °C (green circles) or 4 °C (empty circles) served as a control for an energy-dependent entry mechanism (right
graph). In both cases samples were treated with trypsin before FACS analysis.
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using a GS-710 calibrated Imaging Densitometer (Bio-Rad).
For confocal microscopy, BHK-21 cells seeded on glass cover slips
were incubated with biotinylated P3-25 peptide, extensively washed
and ﬁxed with 4% paraformaldehyde. Cells were subsequently
washed twice in PBS, and then permeabilized for 10 min with 0.2%
Triton X-100 in PBS. Incubations with Strep-FITC were carried out for1 h in PBS containing 0.1% FCS and 0.1% TX-100. Speciﬁc rabbit
policlonal antibodies against the PV 2B protein were diluted 1:300
and incubated for 1 h [29]. For mitochondria staining, cells were
incubated with 2 μM Mitotracker Red for 45 min before ﬁxation. For
endosome co-localization experiments, a monoclonal antibody
(MAb) against EEA1 (BD Transduction Laboratories) was diluted
1:200 and incubated for 1 h.
55V. Madan et al. / Biochimica et Biophysica Acta 1798 (2010) 52–58Flow cytometry samples consisted of P3-25-treated cells for
different times at 37 °C or 4 °C that were washed and incubated
with trypsin (0.05% in EDTA solution) for 5 min. FCS-containing PBS
was added to the detached cells that were then centrifuged and
washed twice in PBS-staining solution (1% bovine serum albumin, 1%
FCS and 0.01% sodium azide in PBS). The cellular pellet was
resuspended gently in 50 μl PBS-staining solution containing 0.3%
saponin and 20 μg/ml Strep-FITC, and incubated at 4 °C for 20 min.
Finally, cells were washed and resuspended in a PBS-staining solution
containing 0.3 % saponin. Fluorescence analyses were performed with
a BD FACScalibur Flow Cytometer (Becton Dickinson Immunocyto-
metry Systems, Mountain View, CA). A minimum of 10,000 events per
sample were included in the analyses.
In mitochondrial permeabilization assays, anti-cytochrome c MAb
(BD Pharmingen; clone 6H2.B4) was diluted 1:100 and incubated for
2 h. Coverslips were washed three times with PBS between primary
and secondary antibody incubations. Alexa 488- or Alexa 594-
conjugated goat anti-mouse and anti-rabbit IgG were used as
secondary antibodies. Coverslips were mounted in ProLong Gold
antifade reagent (Invitrogen) and examined in a Radiance 2000 (Bio-
Rad/Zeiss) confocal laser scanning microscope. Changes in nuclear
morphology were assessed by DAPI (4′,6′-diamino-2-phenilindol) as
described previously [8]. Images as those shown in Fig. 4C–F were
acquired with a FRET microscope (Zeiss) using simultaneously
ﬂuorescence ﬁlters for Alexa 488, DAPI and phase contrast. The
integrity of a caspase-3 substrate, eIF4GI (eukaryotic initiation factor
4GI), was analyzed bywestern blotting employing a rabbit anti-eIF4GI
serum raised against peptides derived from the N- and C-terminal
regions of human eIF4GI at a 1:1000 dilution. An anti-α-tubulin MAb
(Sigma) was used at a 1:1000 dilution to evaluate protein loading.
3. Results and discussion
The PV 2B primary structure reveals the presence of 3 Lys residues
dispersed with helical periodicity that is followed by a short stretch of
hydrophobic amino acids (Fig. 1A, top) (see also references [6,11]). A
previous screening of a complete 2B library identiﬁed a peptide based
on this motif, designated as P3, which was capable of generating pore
structures allowing passage of small solutes across the plasma
membrane of cells growing in culture and boundary bilayers of lipid
vesicles [14]. In order to get a deeper insight into the sequence
requirements of this process, we ﬁrst assessed the importance of the
Lys-based amphipathic stretch for P3–membrane interactions and
pore-forming activity. To that end we produced a series of peptides,
P3–23, P3–18, and P3–15, which were truncated to different extents
at the N-terminus of the P3 sequence (Fig. 1A, bottom).
The left panel of Fig. 1B displays the circular dichroism (CD)
spectra of these peptides in the presence of SDS micelles. P3–23
adopted α-helical structure in solutions containing sodium dodecyl
sulfate (SDS), consistent with its insertion into the membrane-
mimicking detergent micelles. P3–18 exhibited a certain degree of
structuring whereas P3–15 remained largely unstructured and/or
aggregated. Lipid-monolayer and lipid vesicle experiments revealed
that the former structuring behavior correlated with the capacity of
these peptides for inserting into membranes and induce permeabi-
lization (center and right panels, respectively). Thus, P3–23 increased
lateral surface pressure of the lipid monolayer and induced release of
the aqueous contents of lipid vesicles, but these effects were reduced
for P3–18, and almost absent in the case of P3-15. Fig. 1C, D illustrate
the abilities of these peptides to permeabilize cell monolayers. The
ﬂuorography analysis (panel C) shows as a control that single
expression of 2B from a SV replicon induced protein synthesis
inhibition in presence of the translation inhibitor hygromycin B
(HB), a phenomenon reﬂecting the entry of this compound into
permeabilized BHK-21 cells [8]. Addition of P3–23 to the culture
medium also permeabilized cells to HB, thereby inducing 60% ofprotein synthesis inhibition (panel D). P3-18 inhibited protein
synthesis to a lower extent (40%), whereas P3–15 had virtually no
effect, as was the case for untreated controls.
Together, the results displayed in Fig. 1 reinforce the notion that P3
induces cell permeabilization by directly establishing pores in the
plasma membrane, a process primarily mediated by the Lys-based
amphipathic sequence. The presence of cationic residues is also a
hallmark of many pore-forming peptides. According to the current
view, pore-formation and peptide translocation across lipid bilayers
might be coupled events in some instances [15,17–19]. The proposed
models assume that peptides associated to the membrane external
monolayer might assemble into peptide-rich domains, and cause a
local imbalance across the bilayer in packing, surface tension and
charge [20,21,30]. Translocation across the membrane would relieve
such imbalance. This phenomenon is believed to occur through the
formation of transient pores, which might vary in their lifetimes
depending on the peptide species. Thus, within the framework of this
theory, the permeating structures are considered as peptide-shuttling
devices [17].
Therefore, we tested the possibility that P3 could translocate
through the plasma membrane of cells and mark internal compart-
ments (Fig. 2). For these experimentswe used a P3 variantmodiﬁed at
the C-terminus, P3-25, which included an additional Trp residue, a 2
Lys-tag, and a biotin moiety (Fig. 2A). The inclusion of the ﬂuorescent
Trp residue allowed establishing in POPC vesicles a water–membrane
partitioning constant, Kx, in the order of 106 (data not shown). This
value lies in the range of that described for other natural pore-forming
peptides such as melittin [31,32], and conﬁrms that P3–25 is endowed
with a comparable capacity for partitioning from water into lipid
bilayers.
On the other hand, the biotin label allowed ﬂuorescent detection of
P3–25 by means of Strep-FITC binding. Confocal microscopy of
samples treated with the peptide disclosed a ﬂuorescent labeling at
the periphery of the cells, consistent with peptides localized at the cell
surface (NP in Fig. 2B, right). However, further cell permeabilization
revealed an additional intracellular ﬂuorescent labeling (TX-100 in
Fig. 2B, right), which was absent from peptide-untreated control cells
processed otherwise similarly (left panels). This internal labeling was
observed within few minutes after peptide addition and reached its
maximum after ca. 1 h. Similarly, most cells were by that time
internally labeled according to ﬂow cytometry determinations (Fig.
2C and E). Moreover, a strong signal of internalized peptide was
already recovered after 15 min of incubation with peptide (Fig. 2C,
insets). Results in Fig. 2D indicate that a great fraction of cells in
culture were also permeable to HB under those conditions. Fig. 2E
compares peptide-induced permeabilization to HB and internal
labeling as a function of time. The data suggest that both processes
followed parallel kinetics.
Flow cytometry assays were subsequently carried out to deter-
mine whether the peptide uptake process was dependent on active
transport (Fig. 2F). P3-25 was observed to penetrate into BHK cells
efﬁciently at 37 and 4 °C (left and center panels, respectively). In
contrast, control experiments demonstrated that transferrin-FITC
internalization via endocytosis was inhibited at 4 °C in the same
system (right panel). Supporting an energy-independent transloca-
tion mechanism, P3-25 was also observed to localize intracellularly
upon cell ATP depletion, while its internalization kinetics paralleled
that measured in metabolically active cells (data not shown). Thus,
collectively, the ﬁndings described in Fig. 2 provide evidence for the
existence of a correlation between peptide internalization and pore-
formation processes.
A closer inspection to the micrographs obtained by confocal
ﬂuorescence microscopy revealed Strep-FITC labeling of ﬁliform
structures (Fig. 3). This pattern suggested that internalized P3-25
might localize in mitochondria. Putative mitochondrial localization of
P3–25 was therefore assessed by testing its colocalization with
Fig. 3. Localization of internalized P3 peptide by confocal microscopy. (A) BHK cell staining with mitochondrial marker Mitotracker-Red and Strep-FITC in the absence of peptide. (B)
Colocalization of P3-25 with Mitotracker-Red. Cells were treated with P3-25 (1 μM) for 3 h and incubated with Mitotracker-Red before ﬁxation. Next, cells were permeabilized and
stained with Strep-FITC. (C) Absence of colocalization of P3-25 with the endosomal marker anti-EEA1 (Early Endosome antigen 1) antibody. Conditions otherwise as in the previous
panel. (D) Colocalization of PV 2B with Mitotracker-Red. Cells electroporated with a SV replicon construct coding for 2B protein [8] were incubated with the organelle marker. At 8 h
after transfection, cells were permeabilized and stained with anti-2B antibody.
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Red and Strep-FITC labeled similar elongated structures within P3-
treated cells. Both markers colocalization in these samples was
subsequently calculated with the Metamorph software [33]. This
analysis rendered coefﬁcients higher than 0.8 for the Mitotracker Red
vs. Strep-FITC ﬂuorescence intensity correlation (not shown). Fig. 3C
displays a control experiment of colocalization of Strep-FITC with an
endosomal marker (anti-EEA-1 antibody). Analysis of these samples
rendered by comparisonmuch lower correlation coefﬁcients of ca. 0.1.
The confocal microscopy experiments also revealed that the cell
distribution and elongated morphology of mitochondria were similar
in control cells without peptide and in peptide-treated cells (panels A
and B, respectively). In sharp contrast, Mitotraker Red and the full-
length 2B protein expressed from a SV-replicon appeared in
micrographs obtained by confocal microscopy associated with
punctate entities (Fig. 3D). The reorganization of the mitochondrial
network induced by 2B expression was also evident in these
micrographs. This phenomenon resulted in the accumulation of
these organelles around the nucleus.
Overall, the experimental data displayed in Fig. 3 support a
preferential P3–25 association with mitochondria. However, contrary
to the parental 2B protein, the peptide did not induce the
morphological changes that usually accompany mitochondrial mem-
brane disruption. The results shown in Fig. 4 further conﬁrmed that
the P3–25 fraction associated to mitochondria was devoid of the pro-
apoptotic activity exhibited by the parental 2B protein. The mito-
chondrial P3–25 did not increase external membrane permeability to
cytochrome c, as judged from the absence of release of this
apoptogenic compound into the cytoplasm of peptide-treated cells
(Fig. 4A, top). This was again in contrast to the cytochrome c spilling
observed in cells expressing the complete 2B protein (Fig. 4A,bottom). In line with an absence of apoptosis, cells treated with P3–
25 did not exhibit eIF4GI cleavage (Fig. 4B), an evidence of caspase-3
activation that can be observed upon PV 2B expression [8].
As described earlier, the peptide internalization process leveled off
within the ﬁrst hour upon exposure (Fig. 2). After 4 h incubation, no
apoptotic signals were evident in the peptide-treated cells. However,
prolonged incubations with the peptide led to mitochondrial swelling
(Fig. 4E, G). Yet, the cells displaying this abnormal mitochondrial
morphology did not exhibit symptoms of cytochrome c release or
nuclear fragmentation (compare with positive control STS-treated
cells shown in Fig. 4C). Whether this effect was mediated by the
mitochondria-associated peptide fraction, or else the consequence of
the long-lasting plasma membrane permeabilization is difﬁcult to
ascertain. With even longer incubation periods the peptide toxicity
was evidenced by the appearance of rounded cells mostly detached
from the substrate (Fig. 4F). Nevertheless, no evidence of P3–25-
induced apoptosis could be observed even under those conditions of
long exposure to peptide.3.1. Concluding remarks
Our previous characterization led us to propose P3 as a “one-helix”
2B version, which possessed the intrinsic capacity to permeabilize the
cell plasma membrane [14]. Accordingly, we speculated that P3-
induced cell permeabilization could be utilized in high-throughput
screenings to identify viroporin inhibitors, which might in turn result
useful leads for the development of new anti-viral compounds. The
data reported here add to this notion that the P3 pore-forming
activity: (i) requires the preservation of the Lys-based amphipathic
domain (Fig. 1), and (ii) results in P3 internalization (Fig. 2).
Fig. 4. Absence of P3 pro-apoptotic activity. (A) Cytochrome c release assay. Top: cells were ﬁxed after incubation with peptide (1 μM) for 4 h, permeabilized and incubated with anti-
cytochrome c antibody (cyt c). The micrographs display discrete labeling of mitochondria. Bottom: cells expressing PV 2B protein served as positive controls for cytochrome c efﬂux,
which is detected as a ﬂuorescent homogenous staining throughout the cytoplasm (arrow). (B) eIF4GI cleavage assay for caspase-3 activity. BHK cells were incubated with the
peptide for 1 or 16 h, lysated and subjected to SDS-PAGE. A western blotting was performed using a polyclonal anti-eIF4GI antibody. Cells treated with 2 and 0.5% DMSO for 16 h
served as positive and negative controls of apoptosis, respectively. Two typical eIF4GI cleavage products (below 50 kDamarker) by caspase-3 are detected only after incubation with
2% DMSO. A western blotting using monoclonal antibodies against α-tubulin was performed as a control of protein load. (C–F) Effect of P3-25 on nuclei and mitochondria integrity.
Mitochondria morphology and cytochrome c release were assessed in mock cells (panel D) and cells treated with peptide for 8 and 16 h (panels E and F, respectively) using the anti-
cytochrome c antibody (upper panels). Panel C displays a positive control for cytochrome c release that corresponds to cells incubated for 23 h with 1 μM staurosporine (STS). Nuclei
were simultaneously stained with DAPI (middle panels) as described in Material and methods. Corresponding phase contrast images are shown in the lower panels. Bars, 10 μm. (G)
Mitochondrial morphology in mock and P3- to 25-treated cells (right and left panels, respectively). Micrographs are ampliﬁed views of white boxes in panels D and E. Bars, 5 μm.
57V. Madan et al. / Biochimica et Biophysica Acta 1798 (2010) 52–58In addition to the plasma–membrane permeabilizing activity, the
parental PV 2B protein has been recently described to induce apoptosis
via the mitochondrial pathway [8]. This novel effect was proposed torepresent an efﬁcient mechanism to spread newly assembled virions,
evadinghost immune inﬂammatory responsesduring the late phases of
poliovirus infection. In spite of the encouraging ﬁnding that a major P3
58 V. Madan et al. / Biochimica et Biophysica Acta 1798 (2010) 52–58fraction appeared associated with mitochondria (Fig. 3), the internal-
ized peptide was unable to recapitulate the pro-apoptotic effects of 2B
(Fig. 4). Taken together, the experimental evidence reported herein
suggests that the short P3 peptide mimics only partially the activity
displayed by 2B viroporin expressed in cells.
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